Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer

Background: Bisphosphonate (BP) treatment to prevent bone loss in breast cancer patients is already well established. However, data on the association between oral BP exposure before cancer diagnosis and disease outcomes in patients with early breast cancer are still scarce. Limited information is a...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vanessa Rouach, Inbal Goldshtein, Ido Wolf, Raphael Catane, Gabriel Chodick, Amit Iton, Naftali Stern, Daniel Cohen
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2018-09-01
Schriftenreihe:	Journal of Bone Oncology
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2212137418300496
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!